These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 320490)
1. Immunological response of patients with tumors of the urogenital tract: a follow-up of cell-mediated antitumor immunity by the LAI test. Holán V; Heyberger K; Bubeník J; Hasek M; Kanka J; Laurová L Neoplasma; 1977; 24(1):71-9. PubMed ID: 320490 [TBL] [Abstract][Full Text] [Related]
2. [Modulating action of interferon preparations on cellular reactions of antitumor immunity]. Mkrtchian LN; Ter-Pogosian ZR; Sarkisian OM; Gevorkian RA; Movsesian EA Vopr Onkol; 1983; 29(8):7-11. PubMed ID: 6351429 [TBL] [Abstract][Full Text] [Related]
3. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test]. Okada Y Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679 [TBL] [Abstract][Full Text] [Related]
4. Tube LAI assay in diagnosis and monitoring of a cancer disease. Hasek M; Holán V; Kousalová M Biomedicine; 1981 Dec; 35(7-8):207-8. PubMed ID: 7049257 [TBL] [Abstract][Full Text] [Related]
5. Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes. Grosser N; Thomson DM Cancer Res; 1975 Sep; 35(9):2571-9. PubMed ID: 1097110 [TBL] [Abstract][Full Text] [Related]
6. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test]. Ludwig HJ; Storch H Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755 [TBL] [Abstract][Full Text] [Related]
7. Monitoring of antitumor immunity in patients with larynx cancer by tube leukocyte adherence inhibition assay. Holán V; Síbl O; Hasek M Cancer Res; 1979 Feb; 39(2 Pt 2):651-3. PubMed ID: 761230 [TBL] [Abstract][Full Text] [Related]
8. Evidence of cell-mediated antitumor immunity in rats bearing syngeneic tumors by the leukocyte adherence inhibition test. Kalafut F; Hung PM; Novotná L; Grófová M Neoplasma; 1978; 25(5):569-75. PubMed ID: 310970 [TBL] [Abstract][Full Text] [Related]
9. Anti-tumor immunity in breast cancer evaluated by a computerized tube leukocyte adherence inhibition (LAI) assay. Fink A; Shani A; Feldman B; Wechsler U; Pfeffermann R; Eliraz A; Offer S; Harpaz N; Bentwich Z Eur J Surg Oncol; 1989 Feb; 15(1):17-9. PubMed ID: 2645173 [TBL] [Abstract][Full Text] [Related]
10. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay. Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217 [TBL] [Abstract][Full Text] [Related]
11. [Specific immunodiagnosis by cells of mediated anti-tumourous immunity, using the LAI-test (author's transl)]. Heyberger K; Jandová A; Kanka J; Laurová L; Trnka V Cesk Gynekol; 1977 Apr; 42(3):189-90. PubMed ID: 852035 [No Abstract] [Full Text] [Related]
12. [Mechanisms, kinetics and specificity of the leukocyte adherence inhibition test in breast cancer]. Kharkevich DD; Polevaia EB; Derevnina NA; Sablikova IuA; Savinov AIu Eksp Onkol; 1985; 7(6):69-73. PubMed ID: 3910405 [TBL] [Abstract][Full Text] [Related]
13. Assessment of the mechanism of the leukocyte adherence inhibition test. Tong AW; Burger DR; Finke P; Barney C; Vandenbark AA; Vetto RM Cancer Res; 1979 Feb; 39(2 Pt 2):597-603. PubMed ID: 367586 [TBL] [Abstract][Full Text] [Related]
14. LAI reactivity in rats immunized with tumor cells. Pham Manh Hung ; Kalafut F; Novotná L; Koníková E Neoplasma; 1980; 27(4):373-7. PubMed ID: 7005699 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of leukocyte adherence by 3-M potassium chloride extracts of human colorectal tumors. Ichiki AT; Quirin YP; Collmann IR; Sonoda T; Krauss S J Natl Cancer Inst; 1980 Mar; 64(3):419-23. PubMed ID: 6986496 [TBL] [Abstract][Full Text] [Related]
16. Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique. Kotlar HK; Sanner T J Natl Cancer Inst; 1981 Feb; 66(2):265-71. PubMed ID: 7005505 [TBL] [Abstract][Full Text] [Related]
17. [Leukocyte migration inhibition and leukocyte adherence inhibition (LMI- and LAI-assay) in cancer patients by using preparations from human fetuses]. Albrecht S; Thuy LT; Pasternak G; Schlott B; Reinhöfer J; Lunow E; Loewe G; Gütz HJ Acta Biol Med Ger; 1978; 37(11-12):1747-57. PubMed ID: 382722 [TBL] [Abstract][Full Text] [Related]
18. Peripheral blood leukocyte adherence inhibition (LAI) reactivity before and during progressive growth of B77 tumor in rats. Kalafut F; Klobusická M; Novotná L Neoplasma; 1984; 31(5):507-13. PubMed ID: 6390225 [TBL] [Abstract][Full Text] [Related]
19. [Micromodification of the leukocyte adherence inhibition test for cancer patients]. Kharkevich DD; Tabagari DZ; Savinov AIu Vopr Onkol; 1985; 31(7):17-21. PubMed ID: 3895734 [TBL] [Abstract][Full Text] [Related]
20. Comparison of LAI reactivity in B 77 tumor bearing rats between, before and after surgical removal of tumors. Pham Manh Hung ; Kalafut F; Novotná L Neoplasma; 1980; 27(4):367-71. PubMed ID: 7005698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]